Look for:

Our offer for

ELEVANCE HEALTH INC.


ISIN:
US0367521038
WKN:
036752103

- -
Price
-
Difference - (-)

General attributes

ISINUS0367521038
SymbolELV
ExchangeBX Swiss
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)100,461 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)422.443 CHF (48)
Ask (Ask size)424.334 CHF (48)
Open-
High-
Low-
Close (prev. day)-
VWAP-
Volume (pcs)-
Trading volume-
Number of trades-
Last size-

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: ELEVANCE HEALTH INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



- -
Price
-
Difference - (-)

General attributes

ISINUS0367521038
SymbolELV
ExchangeBX Swiss
CurrencyCHF
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)100,461 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)422.443 CHF (48)
Ask (Ask size)424.334 CHF (48)
Open-
High-
Low-
Close (prev. day)-
VWAP-
Volume (pcs)-
Trading volume-
Number of trades-
Last size-

Performance and Risk

6m1Y3Y
Perf (%)---
Perf (abs.)---
Beta0.410.510.75
Volatility---
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)- CHF (-)
Ø price 30 days | Ø volume 30 days (pcs.)- CHF (-)
Ø price 100 days | Ø volume 100 days (pcs.)- CHF (-)
Ø price 250 days | Ø volume 250 days (pcs.)- CHF (-)
YTD High | date- CHF (-)
YTD Low | date- CHF (-)
52 Weeks High | date- CHF (-)
52 Weeks Low | date- CHF (-)

All listings for ELEVANCE HEALTH INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Vienna Stock Exchange2023/03/2909:05425.60 EUR0.001
Tradegate2023/03/2909:37424.25 EUR0.002
Stuttgart2023/03/2908:02424.40 EUR0.001
NYSE2023/03/2822:00458.53 USD399.6324,749
Munich2023/03/2908:00423.30 EUR0.001
London Stock Exchange2023/03/2413:16446.30 USD0.382
Frankfurt2023/03/2908:02423.65 EUR0.001
Duesseldorf2023/03/2912:01424.50 EUR0.005
Berlin2023/03/2908:08424.50 EUR0.001
BX Swiss---0.00-

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2314&ID_TYPE_IMAGE_LOGO=2

Contact Details

ELEVANCE HEALTH INC.
- -
220 Virginia Avenue - 46204 Indianapolis
Telefon: +1-800-331-1476
Fax: +
E-mail: -

PDF Downloads

Company report: ELEVANCE HEALTH INC.PDF Download

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Members of Management Board

Elizabeth TallettChairman of Board of Directors
Bahija JallalMember of Board of Directors
Ryan SchneiderMember of Board of Directors
Antonio NeriMember of Board of Directors
Deanna Strable-SoethoutMember of Board of Directors
Lewis HayMember of Board of Directors
R. ClarkMember of Board of Directors
Ramiro PeruMember of Board of Directors
Robert DixonMember of Board of Directors
Susan DeVoreMember of Board of Directors
Gail BoudreauxChairman of Managing Board
Blair TodtMember of Executive Committee
Felicia F. NorwoodMember of Executive Committee
Gloria McCarthyMember of Executive Committee
John GallinaMember of Executive Committee
Morgan KendrickMember of Executive Committee
Peter D. HaytaianMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer